Goldman Sachs upgrades ing Identity Holding [PING] to Buy and price target to $34
Goldman Sachs took its Ping Identity Holding [PING] rating to the equivalent of Buy from Neutral, and the price target to $34.0, in a research note dated 2021-01-08. That figure represents around a 19.21% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Piper Sandler’s analysts downgrading the […]
Evercore ISI Group upgrades Principal Financial Group to Outperform and price target to $60
Evercore ISI Group took its Principal Financial Group [PFG] rating to the equivalent of Outperform from In-line, and the price target to $60.0 from $49, in a research note dated 2021-01-08. That figure represents around a 15.96% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Goldman’s analysts […]
Deutsche bank cuts Change Healthcare [CHNG]’s rating to Hold; PT at $25.75
Deutsche bank took its Change Healthcare [CHNG] rating to the equivalent of Hold from Buy, and the price target to $25.75, in a research note dated 2021-01-08. That figure represents around a 7.67% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with Citigroup’s analysts assigning the shares […]
RenaissanceRe Holdings [RNR] gets an upgrade to a Buy from Goldman Sachs
Goldman Sachs took its RenaissanceRe Holdings [RNR] rating to the equivalent of Buy from Neutral, and the price target to $199.0, in a research note dated 2021-01-08. That figure represents around a 19.72% premium from where the company’s shares closed on Thursday. Some new analysts also started their coverage, with Citigroup’s analysts assigning the shares […]
Insider Alert: Zendesk Inc. [ZEN]’s Chief of Staff, Geschke John, Makes A $764,060 Sell
On Jan. 05, Geschke John divested U.S. $764,060 in shares of Zendesk Inc.. The Chief of Staff sold 5,500 shares at a price per share of $138.92. The transaction decreased this specific insider’s holdings to 32,195 shares worth around $4.65 million at present. Stifel took its Zendesk Inc. [ZEN] rating to the equivalent of a […]
Deutsche bank downgrade Commercial Metals [CMC] to Hold rating
Deutsche bank took its Commercial Metals [CMC] rating to the equivalent of Hold from Buy, and the price target to $22.0, in a research note dated 2021-01-08. That figure represents around a -5.19% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Exane BNP Paribas’s analysts downgrading the […]
Emergent BioSolutions [EBS] Downgraded to Equal-Weight at Wells Fargo
Wells Fargo took its Emergent BioSolutions [EBS] rating to the equivalent of Equal-Weight from Overweight, in a research note dated 2021-01-08. Meanwhile, Chardan Capital Markets had maintained its rating on EBS to the earlier “Buy” rating, in a research note produced for clients July 31, 2020. In addition, Guggenheim launched coverage on September 12, 2019. […]
BMO Capital upgrades Sabra Health Care REIT to Market Perform and price target to $19
BMO Capital took its Sabra Health Care REIT [SBRA] rating to the equivalent of Market Perform from Underperform, and the price target to $19.0, in a research note dated 2021-01-08. That figure represents around a 11.6% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with JMP Securities’s analysts […]
Insider Selling: 1Life Healthcare Inc. [ONEM] CTO Sells 30,000 Shares Worth $1,294,829
On Jan. 06, Lockhart Kimber D divested U.S. $1,294,829 in shares of 1Life Healthcare Inc.. The CTO sold 30,000 shares at a price per share of $43.16. The transaction decreased this specific insider’s holdings to 70,434 shares worth around $3.0 million at present. BTIG Research launched its 1Life Healthcare Inc. [ONEM] rating to the equivalent […]
Credit Suisse lifts Solid Biosciences [SLDB] rating to Neutral and price target to $7
Credit Suisse took its Solid Biosciences [SLDB] rating to the equivalent of Neutral from Underperform, and the price target to $7.0, in a research note dated 2021-01-08. That figure represents around a -17.45% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with SVB Leerink’s analysts downgrading the shares […]
